Drug Information

Drug General Information
Drug ID
D07EQF
Former ID
DNC004241
Drug Name
V-102862
Drug Type
Small molecular drug
Indication Discovery agent Discontinued in Phase 1 [546691]
Formula
C14H12FN3O2
Canonical SMILES
C1=CC(=CC=C1C=NNC(=O)N)OC2=CC=C(C=C2)F
InChI
1S/C14H12FN3O2/c15-11-3-7-13(8-4-11)20-12-5-1-10(2-6-12)9-17-18-14(16)19/h1-9H,(H3,16,18,19)/b17-9+
InChIKey
MHUUDVZSPFRUSK-RQZCQDPDSA-N
PubChem Compound ID
9816959
Target and Pathway
Target(s) Sodium channel protein type 4 subunit alpha Target Info Inhibitor [526983]
Voltage-gated sodium channel subunit alpha Nav1.7 Target Info Inhibitor [531103]
Reactome Interaction between L1 and AnkyrinsR-HSA-445095:Interaction between L1 and Ankyrins
References
Ref 546691Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009655)
Ref 526983J Med Chem. 2004 Mar 11;47(6):1547-52.3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockers.
Ref 531103Bioorg Med Chem Lett. 2010 Sep 15;20(18):5536-40. Epub 2010 Jul 21.Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.